Hemanext Inc. has secured new venture-capital funding ahead of plans to seek U.S. regulatory authorization for a medical device designed to improve blood storage and help patients who depend heavily on donated blood.
Lexington, Mass.-based Hemanext has collected $15 million in new funding and has now raised a total of more than $100 million.
Donated…
Ladies veterans in Congress and almost 100 Home Democrats are decrying the secretary’s feedback about ladies within the navy. By…
Regional financial institution fears rattle markets; Buyers change the best way they…
By Rick Stroud, Tampa Bay Occasions TAMPA, Fla.— Doug Martin, whose mix…
We independently consider all really useful services and products. Any…
